Regulus Therapeutics Inc (NASDAQ: RGLS) Has Another Chance To Impress You

Currently, there are 20.22M common shares owned by the public and among those 17.42M shares have been available to trade. The company’s stock has a 5-day price change of 59.46% and 68.57% over the past three months. RGLS shares are trading 84.37% year to date (YTD), with the 12-month market performance up to 87.30% higher. […]